This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warren, K. E.
Right arrow Articles by Balis, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warren, K. E.
Right arrow Articles by Balis, F. M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2000, p. 1100-1101, Vol. 44, No. 4
0066-4804/00/$04.00+0

Effect of Fluconazole on the Pharmacokinetics of Doxorubicin in Nonhuman Primates

Katherine E. Warren,* Cynthia M. McCully, Thomas J. Walsh, and Frank M. Balis

Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892-1928

Received 26 February 1999/Returned for modification 23 December 1999/Accepted 18 January 2000

Antifungal prophylaxis in cancer patients who are undergoing chemotherapy is associated with prolonged neutropenia. We measured the effect of fluconazole on doxorubicin pharmacokinetics in nonhuman primates to determine if neutropenia is related to a pharmacokinetic interaction that delays the clearance of the chemotherapeutic agent. Fluconazole pretreatment had no effect on doxorubicin pharmacokinetics.


* Corresponding author. Mailing address: Pediatric Oncology Branch, Bldg. 10/Rm. 13N240, 10 Center Dr., MSC 1928, Bethesda, MD 20892-1928. Phone: (301) 496-1756. Fax: (301) 402-0575. E-mail: warrenk{at}exchange.nih.gov.


Antimicrobial Agents and Chemotherapy, April 2000, p. 1100-1101, Vol. 44, No. 4
0066-4804/00/$04.00+0



This article has been cited by other articles:

  • Marlind, J., Kaspar, M., Trachsel, E., Sommavilla, R., Hindle, S., Bacci, C., Giovannoni, L., Neri, D. (2008). Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy. Clin. Cancer Res. 14: 6515-6524 [Abstract] [Full Text]